Your browser doesn't support javascript.
loading
Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.
Stanley, Takara L; Falutz, Julian; Marsolais, Christian; Morin, Josée; Soulban, Graziella; Mamputu, Jean-Claude; Assaad, Hani; Turner, Ralph; Grinspoon, Steven K.
Affiliation
  • Stanley TL; Program in Nutritional Metabolism, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Clin Infect Dis ; 54(11): 1642-51, 2012 Jun.
Article in En | MEDLINE | ID: mdl-22495074
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Growth Hormone-Releasing Hormone / Anti-HIV Agents / HIV-Associated Lipodystrophy Syndrome / Adiposity Type of study: Clinical_trials / Diagnostic_studies / Guideline / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2012 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Growth Hormone-Releasing Hormone / Anti-HIV Agents / HIV-Associated Lipodystrophy Syndrome / Adiposity Type of study: Clinical_trials / Diagnostic_studies / Guideline / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2012 Type: Article Affiliation country: United States